FDG-PET/CT imaging for evaluating durable responses to immune check point inhibitors in patients with advanced cutaneous squamous cell carcinoma

BACKGROUND: The role of FDG-PET/CT imaging in assessing response to immunotherapy in advanced cutaneous squamous cell carcinoma (CSCC) is unknown. This study compared complete metabolic response (CMR) rates by FDG-PET and RECIST1.1 via CT or MRI in patients on cemiplimab for > 10 months. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: McLean, Luke S., Cavanagh, Karda, Hicks, Rodney J., Callahan, Jason, Xie, Jing, Cardin, Anthony, Lim, Annette M., Rischin, Danny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515684/
https://www.ncbi.nlm.nih.gov/pubmed/34645517
http://dx.doi.org/10.1186/s40644-021-00426-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8515684/
https://www.ncbi.nlm.nih.gov/pubmed/34645517
http://dx.doi.org/10.1186/s40644-021-00426-2

Ejemplares similares